AMOTIO HEALTH LIMITED

Registered Number
16267684
(England and Wales)

Unaudited Financial Statements for the Period ended
28 February 2026

Company Information
for the period from 21 February 2025 to 28 February 2026


Directors	BEE, Daniel John
	FOSTER, Iestyn


Registered Address	Springboard Business Innovation Centre
	Llantarnam Park
	Cwmbran
	NP44 3AW


Registered Number	16267684 (England and Wales)

AMOTIO HEALTH LIMITED

Balance Sheet as at
28 February 2026

		2026 £


Current Assets		962,893
Creditors amounts falling due within one year		(1,710)
Net current assets (liabilities)		961,183

Total assets less current liabilities		961,183

Net assets (liabilities)		961,183
Capital and reserves		961,183

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Average number of employees
The average number of persons employed by the company in the period was 0.
Additional Disclosures
Amotio Ltd is a member of the group, and their bank balance at 31 March 2026 was £21,029. Investments — The company holds 100% of the issued share capital of Amotio B.V., incorporated in the Netherlands, stated at cost of £15. Amotio B.V. holds the entire issued share capital of Amotio Ltd (England and Wales, no. 15567127). The company's principal activity is the research, development and manufacture (including outsourced manufacture), commercialisation, sale, distribution and marketing of medical devices — and related products and solutions — for the diagnosis and surgical treatment of disorders of the joints of the human skeleton, in particular (though not exclusively) the revision surgery of joint implants.

The financial statements were approved and authorised for issue by the Board of Directors on 29 April 2026, and are signed on its behalf by:

FOSTER, Iestyn
Director
Registered Company No. 16267684